Mucosal immunity and viral infections.

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Mucosal surfaces are primary entry points for infectious agents, particularly respiratory and intestinal viruses.
• Viral infections are countered by innate immune responses (cytokines, NK cells) and adaptive responses (T cells, antibodies).
• Secretory IgA antibodies are vital for mucosal immunity against viral infections.

Purpose of the Study:

• To review the immune system's mechanisms against viral infections at mucosal sites.
• To highlight the role of secretory IgA antibodies in viral clearance and protection.
• To discuss the potential of passive antibody transfer and future mucosal vaccines.

Main Methods:

• This is a review of existing research on mucosal immunity and viral infections.
• The abstract synthesizes information on innate and adaptive immune responses.
• It discusses the role of specific antibody types and future vaccine strategies.

Main Results:

• Unspecific immune responses involve type 1 interferons and NK cell activity.
• Specific responses rely on cytotoxic T cells and antibodies, with secretory IgA being key at mucosal sites.
• Passive antibody transfer is a current strategy, while mucosal vaccines represent a future approach.

Conclusions:

• Secretory IgA antibodies are critical for managing viral infections at mucosal surfaces.
• Passive antibody transfer offers therapeutic and prophylactic benefits.
• Mucosal vaccines are anticipated to significantly impact the epidemiology of viral infections.